Immune System News and Research

RSS

Torquetenovirus in people infected by SARS-CoV-2 can be used as a marker of disease severity

Torquetenovirus (TTV) is one of the viruses most frequently found in the human organism. It is also common in monkeys and domestic animals.

8 Nov 2021

Immune system–related differences in dialysis, kidney transplant patients are amplified by SARS-CoV-2

People with kidney failure who are on dialysis or who have received a kidney transplant face a higher risk of dying from COVID-19.

8 Nov 2021

'Rewiring' the mitochondria in macrophages can resolve inflammatory reactions

New data from a research team at Friedrich-Alexander-Universität Erlangen-Nürnberg shows how inflammatory reactions can be resolved by changes to the metabolism of macrophages.

8 Nov 2021

Multiple sclerosis drug improves memory in mouse model of Alzheimer's disease

Losing memory is a hallmark of Alzheimer's, a symptom of the disease that depletes a patient's quality of life. Improving memory and slowing cognitive changes caused by the disease is an ongoing challenge for researchers seeking to develop novel therapies.

8 Nov 2021

Study reveals what causes T cells to be non-responsive to immunotherapy

Non-small cell lung cancer is the most common type of lung cancer in humans. Some patients with NSCLC receive a therapy called immune checkpoint blockade (ICB) that helps kill cancer cells by reinvigorating a subset of immune cells called T cells, which are "exhausted" and have stopped working.

1 Nov 2021

OHSU part of new project investigating stem cell therapy as potential glaucoma treatment

Oregon Health & Science University is part of a national research project investigating stem cell therapy as a potential treatment for glaucoma, the world's second leading cause of blindness.

1 Nov 2021

Study unravels unknown facts about SARS-CoV-2 infection

Around 3%–10% of the individuals infected by the SARS-CoV-2 experience moderate to severe disease.

1 Nov 2021

Immune cell patterns can help predict kidney cancer patients' response to immunotherapy

Researchers at the Francis Crick Institute, The Royal Marsden NHS Foundation Trust and UCL have found immune cell patterns within tumors that can help predict if patients with kidney cancer will respond to immunotherapy.

29 Oct 2021

Correction of immune system's faulty timing may offer a new strategy to prevent severe COVID-19

Once an infection is under control, the body normally uses a biochemical messenger known as TGFβ to downgrade its immune response.

27 Oct 2021

Study identifies a novel role for regulatory protein Bach1 in Parkinson's disease

Parkinson's disease (PD) is the most common neurodegenerative movement disorder, afflicting more than 10 million people worldwide and more than one million Americans. While there is no cure for PD, current therapies focus on treating motor symptoms and fail to reverse, or even address, the underlying neurological damage.

26 Oct 2021

Enteric glial cells play a major role in gut immunity, says new study

Scientists from the Francis Crick Institute unraveled a basic role of glial cells in the nervous system of the gut in retaining a healthy intestine.

22 Oct 2021

Experts develop antibodies that effectively remove senescent cells

The reason why some people age worse than others and develop diseases linked to the aging mechanism is largely unknown.

22 Oct 2021

Researchers reveal how bacteria make liquid protein droplets to survive harsh environments

Scientists have revealed how bacteria make tiny liquid droplets from proteins to help them survive harsh environments and thus reduce their chances of being killed by antibiotics.

21 Oct 2021

Research illustrates the complex mechanism of bacterial innate immunity

Recent research anticipates utilizing newly characterized defense systems in bacteria to match changes to the human genome.

From Durham University 21 Oct 2021

MIT researchers discover new way to awaken the immune system to attack tumors

Immunotherapy is a promising strategy to treat cancer by stimulating the body's own immune system to destroy tumor cells, but it only works for a handful of cancers. MIT researchers have now discovered a new way to jump-start the immune system to attack tumors, which they hope could allow immunotherapy to be used against more types of cancer.

From Massachusetts Institute of Technology (MIT) 20 Oct 2021

Immune System News and Research

Torquetenovirus in people infected by SARS-CoV-2 can be used as a marker of disease severity

Immune system–related differences in dialysis, kidney transplant patients are amplified by SARS-CoV-2

'Rewiring' the mitochondria in macrophages can resolve inflammatory reactions

Multiple sclerosis drug improves memory in mouse model of Alzheimer's disease

Study reveals what causes T cells to be non-responsive to immunotherapy

OHSU part of new project investigating stem cell therapy as potential glaucoma treatment

Study unravels unknown facts about SARS-CoV-2 infection

Immune cell patterns can help predict kidney cancer patients' response to immunotherapy

Correction of immune system's faulty timing may offer a new strategy to prevent severe COVID-19

Study identifies a novel role for regulatory protein Bach1 in Parkinson's disease

Enteric glial cells play a major role in gut immunity, says new study

Experts develop antibodies that effectively remove senescent cells

Researchers reveal how bacteria make liquid protein droplets to survive harsh environments

Research illustrates the complex mechanism of bacterial innate immunity

MIT researchers discover new way to awaken the immune system to attack tumors

Scientists reveal the importance of circadian rhythm on the immune system

High tumor-infiltrating lymphocytes could indicate a better chance of survival in esophageal cancer

Metabolic restoration could provide natural protection against HIV

Study identifies highly potent monoclonal antibody against all SARS-CoV-2 variants

Researchers develop chimeric exosomes that co-activate immune response and tumor microenvironment

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics